Lisa Mateo-Madison Muller
Bloomberg Health Reporter, covering the pharmaceutical industry and health-related business news.
Best podcasts with Lisa Mateo-Madison Muller
Ranked by the Snipd community
Aug 18, 2025 • 20min
Novo Halves Ozempic Price to $499 a Month For Those Paying Cash
Lisa Mateo-Madison Muller, a Bloomberg Health Reporter, dives into Novo Nordisk's decision to cut Ozempic's price to $499 monthly for cash payers, highlighting its potential to improve accessibility. She discusses the broader implications for pharmaceutical pricing and patient care. The conversation also touches on Novo’s recent approval of Wegovy for treating serious liver disease and its competitive edge against Eli Lilly’s offerings. Plus, insights into the strategic partnerships formed to enhance access for uninsured individuals add an interesting twist!
